ResMed Inc. (RSMDF)

Market Cap	42.21B
Revenue (ttm)	5.15B
Net Income (ttm)	1.40B
Shares Out	n/a
EPS (ttm)	9.51
PE Ratio	30.13
Forward PE	26.35
Dividend	n/a
Ex-Dividend Date	n/a

Volume	159
Average Volume	3,590
Open	16.63
Previous Close	16.57
Day's Range	16.63 - 16.63
52-Week Range	11.91 - 30.00
Beta	0.77
RSI	13.31
Earnings Date	Jul 31, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 9,980
• Stock Exchange: OTCMKTS
• Ticker Symbol: RSMDF

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.